Key takeaways:
- The highest-yield microplastic exposure reduction strategies—avoiding microwaving in plastic, reducing plastic bottle use, and transitioning to glass or stainless steel storage—should be framed as empowering incremental changes, not an overwhelming overhaul.
- Persistent urgency, leakage, recurrent negative-culture UTIs, hematuria, pelvic pain, and any bladder symptoms affecting sleep, intimacy, or daily function warrant thorough evaluation regardless of patient age.
- Normalization of bladder symptoms in female patients delays diagnosis and care; referral to urology or urogynecology is appropriate when symptoms persist despite initial management, cultures are persistently negative, or pain becomes complex.
Reducing microplastic and nanoplastic exposure does not require an expensive lifestyle overhaul—and framing it that way to patients does more harm than good, according to Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES, the founder of the Fosnight Center for Sexual Health and a medical advisor for Aeroflow Urology, who addressed both practical exposure reduction and the underrecognized problem of delayed bladder care in ob-gyn settings.
On microplastic exposure, Fosnight's central message was that accessible, incremental change outperforms the pursuit of perfection.
"We don't need everybody switching everything overnight—taking one little thing at a time, on a daily basis or even on a weekly basis, can be really helpful," she said. She directed patients toward the highest-yield interventions first: Do not microwave food in plastic containers, reduce plastic bottled water use, choose fragrance-free products when accessible and feasible, and transition to glass or stainless steel food storage over time.
"If that's the only thing you take away from this, just don't microwave plastic," she said.
Fosnight also pushed back against the anxiety spiral that detailed exposure counseling can inadvertently trigger.
"Stress itself can greatly impact your health—we don't need patients spiraling over every single plastic exposure," she said. The goal is empowerment, not overwhelm. Small, repeated daily shifts will meaningfully reduce exposure burden without requiring patients to feel that every product in their home is a health hazard.
On bladder health, Fosnight identified a pattern of normalization in ob-gyn practice—particularly in younger patients—that she described as a driver of delayed diagnosis and care.
"Young age does not protect patients from bladder dysfunction," she said. Symptoms that warrant thorough evaluation include persistent urgency or leakage, recurrent urinary tract infections, pain with sexual activity, pelvic pain, hematuria, incomplete bladder emptying, and any bladder-related disruption to sleep, intimacy, or daily function.
Referral to urology or urogynecology is appropriate when symptoms persist despite initial treatment, when urine cultures repeatedly return negative despite ongoing symptoms, when hematuria is present—especially visible blood—or when pelvic floor dysfunction involves complex pain.
"When you think about blood in the urine, especially visual blood that somebody is seeing, I really want us to pull in our colleagues to figure out what's going on," Fosnight said.
The normalization of bladder symptoms in women, she argued, is itself a clinical problem.
"We normalize bladder symptoms far too frequently, especially in our female-identified individuals—and that normalization is going to delay care," she said. Treating urgency, leakage, or pelvic pain as an expected and unremarkable feature of female anatomy forecloses the evaluation and treatment that many patients need and deserve.
